Macrobiome Therapeutics is developing next-generation biologics for treating disorders that result from a dysfunctional immune system. Our drug discovery ethos is underpinned by millennia of host-parasite co-evolution. Parasitic worms have evolved to survive in their vertebrate hosts while causing minimal pathology, a relationship that has been fine tuned for millions of years. We are harnessing the therapeutic potential of parasites to develop the next generation of biologics inspired by nature”.

Key publications:

Scroll to Top